Member Info for BigDano

Very good Muck & Gubbie great to see this confirmation & the Cognizant partnership is also a key detail buried in that blog. Read it again carefully: "Abingdon is proud to partner with Cognizant on delivering innovative near-patient testing solutions to national health services."

Having a named CDx partnership with a €55M-funded Phase 1b/2a drug targeting an indication with 50%+ mortality, no approved competition, DPP3 biomarker validated across 100,000+ patients, and Abingdon holding the legal manufacturer designation — this is the highest-quality single contract announcement in Abingdon's post-COVID history.

It doesn't change the near-term revenue picture materially. But it does something more important for a micro-cap at this stage: it validates that serious, well-capitalised European pharma companies are choosing Abingdon as their CDx manufacturing partner for drugs with genuine commercial potential.

Critically 4TEEN4 has the money to see this through. 4TEEN4 extended its Series C financing round to €55 million in November 2025, supporting expanded clinical development of procizumab. The company dosed the first patient in its PROCARD 1b/2a trial in July 2025 and expected first interim PK/PD and safety results in early 2026. A €55M Series C for a Phase 1b/2a drug in a validated indication with no competition is a serious funding position

I’m afraid neither company has confirmed that is the case, it would be great if there’s evidence that this is happening..

No direct link to LVOne so wouldn’t be getting too excited!.. Good to see that the NA retail investors are making a difference with the rise today. Another contract announcement would be most timely.

Any mention by management on AffyXell?

Agreed Muck165, no indication of what capital investment is needed to build out the NA facility which doesn’t help and we need mgt to be more transparent about these key decisions

The good news on this is that it helps build a positive reputation in the NA market with having this NA customer published success story.

At-home saliva test for prostate cancer better than blood test, study suggests

https://www.theguardian.com/society/2025/apr/09/at-home-saliva-test-for-prostate-cancer-better-than-blood-test-study-suggests?CMP=Share_iOSApp_Other

Interestingly the Boots Vitamin D Rapid test is made by Hangzhou Alltest Biotech from China, maybe Boots had a contract with them originally that’s now with Abingdon and the stock needs to sold before restocking all stores with our test?, could this be a reason why the revenue from the rapid tests is not yet fully coming through. This test was purchased in an Irish Boots store maybe worth checking your local boots to see if it’s our test that’s stocked!!.

Nice work Muck165!..

I have done my small bit for the SP and purchased the iron test from Boots. I was surprised though that it was behind the counter! One would imagine this is affecting sales if it’s the same situation in every Boots store.

“ Over 100k tests delivered in the UK over in recent months”. - https://www.new-techeurope.com/2024/07/17/salignostics-saliva-based-pregnancy-test-to-be-sold-at-boots-uks-leading-health-and-beauty-retailer/

Looking forward to getting revenue numbers next week that might give us insights to future solid revenue streams..

Great to see positive news flowing through, been here a long time & finally some positive signals to top up with the recent positive developments

Thankfully we had a clause to cover future payments on the value of covid products in the Launch D acquisition which is now costing Avacta zero.

'The additional consideration to be paid based on future gross margin is estimated to be nil as at 31 December 2022'

Monumental news. Needs to get out to the media as the public/gov/big pharma needs to be aware of such trials so that this gets the required attention..

https://lp.abingdonhealth.com/something-big-is-coming?

And will we see an announcement tomorrow on the Avacta TT completion........

Not a good sign that in today's interm results update by ABDX where they are giving a positive spin on all key business items that this is what they has to say about our TT...

We were disappointed with the pause in the transfer of Avacta Group plc's ("Avacta") A?DX® SARS-CoV-2 antigen lateral ?ow tests, following the successful preparation of three batches of its product which adhered to the agreed speci?cations and passed all quality control procedures.

And we issue a conference poster RNS on the same day. Hmmmm....

Delighted they are dropped, the DVRG mgt team is very weak. Worked with a couple of them in the past and the CEO definitely didn't do his due diligence when he hired someone onto his mgt team who then pulled in another shady character. It happens and thus companies fail. Avctva mgt probably quickly figured this out after they initially investing time at the start of the parnership.

https://goodlawproject.org/update/high-court-vip-lane-ppe-unlawful/